A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy.
about
Current and emerging treatment strategies for Duchenne muscular dystrophyClinical utility of serum biomarkers in Duchenne muscular dystrophyCritical Role of Intracellular RyR1 Calcium Release Channels in Skeletal Muscle Function and DiseaseDystrophin-deficient large animal models: translational research and exon skippingAdvances in gene therapy for muscular dystrophiesWhat can Duchenne Connect teach us about treating Duchenne muscular dystrophy?The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence reviewQuantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy.Serum Creatinine Distinguishes Duchenne Muscular Dystrophy from Becker Muscular Dystrophy in Patients Aged ≤3 Years: A Retrospective Study.Proteomic profiling of mdx-4cv serum reveals highly elevated levels of the inflammation-induced plasma marker haptoglobin in muscular dystrophy.A classical phenotype of Duchenne muscular dystrophy in a girl with X; autosome translocation.Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in GermanyLong-term efficacy of systemic multiexon skipping targeting dystrophin exons 45-55 with a cocktail of vivo-morpholinos in mdx52 micePsychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study.The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations.Large-scale serum protein biomarker discovery in Duchenne muscular dystrophyImperatives for DUCHENNE MD: a Simplified Guide to Comprehensive Care for Duchenne Muscular DystrophyPrevalence of Duchenne and Becker muscular dystrophies in the United States.Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study.A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment.A case report: Becker muscular dystrophy presenting with epilepsy and dysgnosia induced by duplication mutation of Dystrophin gene.Non-invasive evaluation of muscle disease in the canine model of Duchenne muscular dystrophy by electrical impedance myography.Prevalence and Genetic Profile of Duchene and Becker Muscular Dystrophy in Puerto RicoPathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis.A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies.The prevalence of neuromuscular disease in the paediatric population in Yorkshire, UK; variation by ethnicity and deprivation status.Clinical Follow-Up for Duchenne Muscular Dystrophy Newborn Screening: A Proposal.Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentation.Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis.Advances in the Treatment of Duchenne Muscular Dystrophy: New and Emerging Pharmacotherapies.Nanotherapy for Duchenne muscular dystrophy.Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.Delivery of large transgene cassettes by foamy virus vector.Health care utilization and costs for children and adults with duchenne muscular dystrophy.The PJ Nicholoff Steroid Protocol for Duchenne and Becker Muscular Dystrophy and Adrenal Suppression.Progression of Duchenne Cardiomyopathy Presenting with Chest Pain and Troponin Elevation.Efficacy of Idebenone to Preserve Respiratory Function above Clinically Meaningful Thresholds for Forced Vital Capacity (FVC) in Patients with Duchenne Muscular Dystrophy.Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscleImproving translational studies: lessons from rare neuromuscular diseases.Are mice good models for human neuromuscular disease? Comparing muscle excursions in walking between mice and humans.
P2860
Q26741535-F1C9BB1B-B110-4390-9D4C-810C87C27B34Q26751261-F7138B24-2B33-4BCE-8975-9102C368049CQ26770423-1E0FA836-043A-48C3-9807-23512B22E4EBQ26781901-C6444380-4AA7-419E-9DE3-C0CDAFE29407Q28073994-16BB4454-6493-4EA3-A1CA-B13D8FA8597FQ28080926-73E542AF-9FBA-44F8-B725-22C9B2C1ECC9Q30234649-219FBC38-0A3E-4971-B6EB-FF435EF80D79Q30983066-7865CD81-4689-4602-B437-283EC5433148Q33646732-A942E898-C084-4E8C-BEE7-F66E847909C6Q33675040-946807F2-3A38-4228-B13C-7580F77DE37FQ34998042-B01DF5AC-3662-4245-81F2-A0B842E59252Q34998724-D651B02E-7BE5-4431-8EA4-4161CA636828Q35133936-51085E7A-A86C-4713-9A76-FDCE2C55D6F2Q35206606-76FAF7D8-4D9B-4562-99C9-A8403719888FQ35508913-EFC3C703-ADC8-4157-A590-8AF46B4AE9C4Q35740280-216AD0E6-AFC1-49AF-B3BC-B940108EFF36Q35761932-F9583D2D-0656-472F-A2FF-A706AFEEA221Q35770545-58963E98-227B-42A2-A598-F58F5A0CF578Q35991086-6A957548-16C9-4577-8F11-625DF1764411Q36043426-B1EFCCF2-871C-4EA3-9468-7508A1BEFACDQ36220734-D5A67008-563D-4896-A444-A7F35B75B7ADQ36322048-736181D6-2657-4B65-9B97-5A84FFE57EE4Q37425767-09FFD68F-D9C9-4825-9288-5F34BD6EED2AQ38563300-77B88CA5-1373-4B38-9120-CB50524CB2EDQ38703274-7C82FD90-C3D6-4E7B-ADEF-9CB695DA6048Q38770622-576ABF2D-DEC4-4892-8BC5-E8C9968520ECQ38832537-08747D32-3E1F-484B-A5CF-44A5F67CEB14Q38850056-CFAD7020-00C0-431C-874B-81EDD40FFAE4Q39033229-1E245AA8-BF0E-4440-AB69-8435F6A94EFAQ39115626-065D988C-733C-4FED-9E91-DAEA315C68B9Q39233936-4BCDF14A-C708-493E-AEBD-58580B47BFC8Q39869199-B62EDDA0-7B9C-43AE-B9CC-3E2AF953034FQ40083126-F72E6D19-BF20-4E4D-908F-2E1F88EBFBE2Q40327921-FA480E28-4F0B-4A00-9146-034160E717BFQ40984650-C682C8D4-8A75-439C-AB91-A6259387ABC2Q41922953-F35C127C-3EF6-47ED-A665-BB47B4DFABDFQ42363355-8C56A582-9241-4081-A47B-F8F71C9999FCQ42634544-B2ECE95B-2DE6-4AF7-AAB4-AB2BB2B6F910Q43214157-36FE6EA7-D23C-4656-86C1-9525965C4CB4Q45073133-B42F674F-3BA0-4772-BBAB-110CDF685D22
P2860
A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A systematic review and meta-a ...... and Becker muscular dystrophy.
@ast
A systematic review and meta-a ...... and Becker muscular dystrophy.
@en
A systematic review and meta-a ...... and Becker muscular dystrophy.
@nl
type
label
A systematic review and meta-a ...... and Becker muscular dystrophy.
@ast
A systematic review and meta-a ...... and Becker muscular dystrophy.
@en
A systematic review and meta-a ...... and Becker muscular dystrophy.
@nl
prefLabel
A systematic review and meta-a ...... and Becker muscular dystrophy.
@ast
A systematic review and meta-a ...... and Becker muscular dystrophy.
@en
A systematic review and meta-a ...... and Becker muscular dystrophy.
@nl
P2093
P1476
A systematic review and meta-a ...... and Becker muscular dystrophy.
@en
P2093
Jean K Mah
Jonathan Dykeman
Lawrence Korngut
Tamara Pringsheim
P304
P356
10.1016/J.NMD.2014.03.008
P577
2014-03-22T00:00:00Z